Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statistical methods for population pharmacokinetic modelling

A Racine-Poon1, J Wakefield

  • 1Pharma Division, Novartis, Basel, Switzerland. wara@chbs.ciba.com

Statistical Methods in Medical Research
|April 9, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Importance of case age in the purported association between phylogenetics and hemolytic uremic syndrome in <i>Escherichia coli</i> O157:H7 infections - ERRATUM.

Epidemiology and infection·2019
Same author

Responding to Mycobacterium chimaera heater-cooler unit contamination: international and national intersectoral collaboration coordinated in the state of Queensland, Australia.

The Journal of hospital infection·2018
Same author

Importance of case age in the purported association between phylogenetics and hemolytic uremic syndrome in Escherichia coli O157:H7 infections.

Epidemiology and infection·2018
Same author

Hyak mortality monitoring system: innovative sampling and estimation methods - proof of concept by simulation.

Global health, epidemiology and genomics·2018
Same author

Association of meteorological and geographical factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis.

Epidemiology and infection·2015
Same author

Detecting signals in pharmacogenomic genome-wide association studies.

The pharmacogenomics journal·2014
Same journal

A joint model for a longitudinal outcome and a progressive multistate model under a mixed observation scheme.

Statistical methods in medical research·2026
Same journal

Efficient semi-supervised estimation of optimal individualized treatment regimes with survival outcome.

Statistical methods in medical research·2026
Same journal

Asymptotic online FWER control for dependent test statistics.

Statistical methods in medical research·2026
Same journal

Regression analysis of misclassified current status data with potentially unknown test accuracy.

Statistical methods in medical research·2026
Same journal

Bayesian multivariate linear mixed-effects models with varied association structures.

Statistical methods in medical research·2026
Same journal

Inference about the ratio of age-standardized rates between two overlapping populations.

Statistical methods in medical research·2026
See all related articles

Population pharmacokinetic studies aim to quantify drug variability. This review explores various methods for estimating these variances and explaining them with covariates.

Area of Science:

  • Pharmacometrics
  • Pharmacokinetics
  • Statistical Modeling

Background:

  • Population pharmacokinetic (Pop-PK) studies are crucial for understanding drug behavior in diverse patient groups.
  • Estimating variance components (intra- and inter-individual) in drug concentrations is a key objective.
  • Explaining inter-individual variability using subject-specific covariates enhances treatment personalization.

Purpose of the Study:

  • To review and categorize existing estimation approaches for population pharmacokinetic analyses.
  • To differentiate between Bayesian and non-Bayesian methodologies.
  • To highlight the distinctions between fully-parametric, semi-parametric, and non-parametric methods.

Main Methods:

  • Review of established and novel estimation techniques in population pharmacokinetics.

Related Experiment Videos

  • Categorization based on statistical paradigms: Bayesian vs. non-Bayesian.
  • Classification based on model structure: fully-parametric, semi-parametric, and non-parametric.

    • Main Results:

    • Identified a range of estimation strategies for Pop-PK data.
    • Established a clear distinction between Bayesian and non-Bayesian frameworks.
    • Differentiated methods based on their parametric assumptions.

    Conclusions:

    • The choice of estimation method impacts the accuracy of Pop-PK parameter and variance component estimation.
    • Understanding these methods is vital for robust pharmacokinetic modeling.
    • Further research may focus on optimizing methods for complex Pop-PK models.